After Hours
$
160.50
Change
+0.20 +0.12%
Volume
Volume 203,415
Jan 15, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 160.65
$ 160.30
Change
-0.35 -0.22%
Day low
Day high
$159.11
$161.41

52 week low
52 week high
$109.16
$161.95

Market cap
$422.00B
Average volume
7.66M
P/E ratio
25.19
Rev. per Employee
$603,509
EPS
6.36
Dividend
1.01
Div yield
2.52%
Ex dividend date
2/22/21
MarketWatch News on JNJ
-
Fear Comes to the Stock Market. What Comes Next.
- Ben Levisohn
-
Barron’s 2020 Quiz Winner Gets an Unusually High Score
- Andrew Bary
-
Global Dividends Will Rise 7% in 2021, IHS Markit Says, but U.S. Payouts Seen Falling
- Lawrence C. Strauss
-
Dow's 69-point climb highlighted by gains for shares of Intel, Chevron
- MarketWatch Automation
-
Boeing, Johnson & Johnson share gains contribute to Dow's 150-point climb
- MarketWatch Automation
-
New Data Boosts Confidence In J&J Vaccine
- Josh Nathan-Kazis
-
The Dow Slipped 8 Points, but Big Tech Stocks Powered Higher
- Jacob Sonenshine
-
Here are the 10 best places to work in 2021, according to employees
- Nicole Lyn Pesce
-
Johnson & Johnson Hits Vaccine Production Snags, New York Times Reports
- Josh Nathan-Kazis
-
Why ‘quacks’ and bubbles can so easily proliferate
- Steve Goldstein
-
Johnson & Johnson vaccine production is behind schedule: report
- Steve Goldstein
-
Pfizer Is Ready for a Long Battle Against Covid-19
- Josh Nathan-Kazis
-
Moderna Executives Say Covid-19 Vaccine Should Offer a Year of Protection
- Josh Nathan-Kazis
-
J&J’s Vaccine Could Transform the Pandemic. We’ll Soon Know if It Works.
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Analysts Are Overwhelmingly Bullish on Abbott Laboratories
- MarketRealist.com
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Wall Street’s Views on BSX’s Acquisition of Cryterion Medical
- MarketRealist.com
Other News on JNJ
-
Dividend Income Update December 2020
- Seeking Alpha
-
Genmab's therapy for AL amyloidosis receives FDA approval
- Seeking Alpha
-
IPO Update: Vallon Pharmaceuticals Proposes IPO Terms
- Seeking Alpha
-
Moderna Insiders Begin To Cash Out
- Seeking Alpha
-
Stocks Slip Ahead of Biden’s Stimulus Speech
- Anna Hirtenstein
-
Netflix Stock Remains Well Ahead of the Competition
- InvestorPlace.com
-
7 Great Index Funds To Buy With Super Low Fees
- InvestorPlace.com
-
31 Of 50 Billionaire January-Held Stocks Pay Dividends
- Seeking Alpha
-
A Dividend Investor's Guide To 2021: The Cure To Uncertain Times
- Seeking Alpha
-
The world will have to live with COVID forever - Moderna CEO
- Seeking Alpha
-
JNJ’s COVID-19 vaccine data published in Medical Journal
- Seeking Alpha
-
7 Pharmaceutical Stocks With Exciting Plans for 2021
- InvestorPlace.com
-
J&J Opposes Former Talc Supplier’s Bankruptcy Plan
- Peg Brickley
- Loading more headlines...
Press Releases on JNJ
-
- Baystreet.ca
-
Best Biotech Stocks For 2021? 3 Names Trending This Week
- StockMarket.com
-
- Baystreet.ca
-
Four Game-Changing Medical Cannabis Small Caps
- IAM Newswire
-
Hemostats Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
- SUPER MARKET RESEARCH
-
Daily Dividend Report: CVS,JNJ,RPM,AFIN,AFG
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2021
- PR Newswire - PRF
-
Psychedelics Industry Gearing Up For an Even Bigger 2021
- Financial News Media
-
Psychedelics Industry Gearing Up For an Even Bigger 2021
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com